ADMA Biologics is a biotechnology business based in the US. ADMA Biologics shares (ADMA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $20.45 – a decrease of 11.55% over the previous week. ADMA Biologics employs 685 staff and has a trailing 12-month revenue of around $426.5 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $20.45 |
|---|---|
| 52-week range | $8.42 - $25.67 |
| 50-day moving average | $19.84 |
| 200-day moving average | $18.08 |
| Wall St. target price | $26.49 |
| PE ratio | 24.6667 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.81 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $19.98 from 2025-05-09
| 1 week (2025-05-07) | -15.37% |
|---|---|
| 1 month (2025-04-14) | -4.45% |
| 3 months (2025-02-14) | 25.66% |
| 6 months (2024-11-14) | -1.09% |
| 1 year (2024-05-14) | 118.12% |
|---|---|
| 2 years (2023-05-12) | 373.46% |
| 3 years (2022-05-13) | 1,035.23% |
| 5 years (2020-05-13) | 702.41% |
Valuing ADMA Biologics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ADMA Biologics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ADMA Biologics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, ADMA Biologics shares trade at around 25x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
ADMA Biologics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $147 million.
The EBITDA is a measure of a ADMA Biologics's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $426.5 million |
|---|---|
| Operating margin TTM | 32.6% |
| Gross profit TTM | $219.6 million |
| Return on assets TTM | 21.24% |
| Return on equity TTM | 81.64% |
| Profit margin | 46.35% |
| Book value | $1.48 |
| Market Capitalization | $4.8 billion |
TTM: trailing 12 months
We're not expecting ADMA Biologics to pay a dividend over the next 12 months.
Over the last 12 months, ADMA Biologics's shares have ranged in value from as little as $8.4233 up to $25.67. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ADMA Biologics's is 0.571. This would suggest that ADMA Biologics's shares are less volatile than average (for this exchange).
ADMA Biologics, Inc. , a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers.
We dug through 60 years of Berkshire Hathaway annual shareholder letters to bring you 9 lessons from Warren Buffett: “The Oracle of Omaha.”
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Thinking of switching from Moomoo? Here are 5 apps like Moomoo that offer valuable benefits
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
Here’s what you need to know about how to buy and sell stocks online in this easy to follow, step-by-step guide.